- Home
- UBX vs AMOD Comparison
UBX vs AMOD Comparison
Compare UBX & AMOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBX
- AMOD
- Stock Information
- Founded
- UBX 2009
- AMOD 2014
- Country
- UBX United States
- AMOD United States
- Employees
- UBX N/A
- AMOD N/A
- Industry
- UBX Biotechnology: Pharmaceutical Preparations
- AMOD
- Sector
- UBX Health Care
- AMOD
- Exchange
- UBX Nasdaq
- AMOD NYSE
- Market Cap
- UBX 20.4M
- AMOD 16.7M
- IPO Year
- UBX 2018
- AMOD N/A
- Fundamental
- Price
- UBX $0.99
- AMOD $1.21
- Analyst Decision
- UBX Strong Buy
- AMOD
- Analyst Count
- UBX 3
- AMOD 0
- Target Price
- UBX $5.33
- AMOD N/A
- AVG Volume (30 Days)
- UBX 148.7K
- AMOD 61.9K
- Earning Date
- UBX 04-22-2025
- AMOD 05-15-2025
- Dividend Yield
- UBX N/A
- AMOD N/A
- EPS Growth
- UBX N/A
- AMOD N/A
- EPS
- UBX N/A
- AMOD 0.13
- Revenue
- UBX N/A
- AMOD N/A
- Revenue This Year
- UBX N/A
- AMOD N/A
- Revenue Next Year
- UBX N/A
- AMOD N/A
- P/E Ratio
- UBX N/A
- AMOD $9.36
- Revenue Growth
- UBX N/A
- AMOD N/A
- 52 Week Low
- UBX $0.85
- AMOD $1.02
- 52 Week High
- UBX $3.10
- AMOD $13.49
- Technical
- Relative Strength Index (RSI)
- UBX 37.79
- AMOD N/A
- Support Level
- UBX $0.91
- AMOD N/A
- Resistance Level
- UBX $1.07
- AMOD N/A
- Average True Range (ATR)
- UBX 0.09
- AMOD 0.00
- MACD
- UBX 0.03
- AMOD 0.00
- Stochastic Oscillator
- UBX 61.29
- AMOD 0.00
About UBX Unity Biotechnology Inc.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
About AMOD ALPHA MODUS HOLDINGS INC
Alpha Modus Holdings Inc is a technology company with a core focus on artificial intelligence in retail. It is engaged in creating, developing and licensing data-driven technologies to enhance consumers' in-store digital experience at the point of decision.